Latest filing published 18 Aug 2026 for BIO-TECHNE Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Steven C. Crouse has filed trades across 2 companies (mainly through SEC (Form 4)), most often in BIO-TECHNE Corp and OmniAb, Inc. The record holds 8 filings, for trades running from 21 April 2026 to 15 August 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 18 August 2026, reports an option exercise in BIO-TECHNE Corp. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations